UBS Group
CING icon

UBS Group’s Cingulate CING Stock Holding History

UBS Group’s Portfolio CING Stock Details CING Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
25,947
+14,914
+135% +$75.2K ﹤0.01% 6996
2026
Q1 		$68.5K Sell
11,033
-16,651
-60% -$106K ﹤0.01% 7198
2025
Q4 		$120K Buy
27,684
+26,386
+2,033% +$102K ﹤0.01% 6813
2025
Q3 		$5.09K Sell
1,298
-11,347
-90% -$49.1K ﹤0.01% 8898
2025
Q2 		$51.5K Sell
12,645
-9,471
-43% -$38.7K ﹤0.01% 7744
2025
Q1 		$95.1K Buy
22,116
+9,920
+81% +$43.2K ﹤0.01% 7083
2024
Q4 		$60.1K Sell
12,196
-1,553
-11% -$6.8K ﹤0.01% 7183
2024
Q3 		$69.3K Buy
+13,749
New +$77.9K ﹤0.01% 6604
2023
Q4 		– Sell
-1
Closed -$99 – 9362
2023
Q3 		$99 Buy
+1
New +$163 ﹤0.01% 8886
2023
Q2 		– Sell
-4
Closed -$829 – 8992
2023
Q1 		$829 Sell
4
-24
-86% -$6.39K ﹤0.01% 8892
2022
Q4 		$6.72K Sell
28
-35
-56% -$8.63K ﹤0.01% 8993
2022
Q3 		$16K Buy
+63
New +$21.8K ﹤0.01% 7675
2022
Q1 		– Sell
-20
Closed -$13K – 10309
2021
Q4 		$13K Buy
+20
New +$14.1K ﹤0.01% 8439

Other funds holding CING

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $3.31B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS Group's CING Position: Q2 2026 in Review

UBS Group increased its Cingulate (CING) stake by 135% in Q2 2026, buying an estimated $75.2K and bringing the position to 25,947 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #6996.

UBS Group first reported a position in CING in Q4 2021 and has held it in 13 quarters since. 32 funds tracked by Wall St. Rank hold CING as of Q2 2026.

  • UBS Group held 25,947 shares of Cingulate worth $142K as of Q2 2026.
  • UBS Group bought 14,914 Cingulate shares in Q2 2026, an estimated $75.2K.
  • Cingulate made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6996 holding.
  • UBS Group first reported a position in Cingulate in Q4 2021 and has held it in 13 quarters since.
  • 32 funds tracked by Wall St. Rank held Cingulate as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.